Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cancer Research

• Publication date

  1990-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2208176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

  1990cited by this paper
• Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.

  1990cited by this paper
• Allelotype of colorectal carcinomas.

  1989cited by this paper
• Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

  1988cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Chromosomal analysis of bladder cancer. III. Nonrandom alterations.

  1987cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper
• Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.

  1986cited by this paper
• Loss of genes on the short arm of chromosome 11 in bladder cancer

  1985cited by this paper
• Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.

  1984cited by this paper
• T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes

  1982cited by this paper
• Epithelial Tumors of the Bladder1

  1940cited by this paper

• Molecular Oncology of Bladder Cancer from Inception to Modern Perspective

  2022cites this paper
• ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma

  2022cites this paper
• Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles

  2022cites this paper
• Comparison of P53 Protein Overexpression With P53 Mutation In Bladder Cancer: Clinical and Biologic Aspects

  2019cites this paper
• Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm

  2018cites this paper
• Prognostic value of P53 nuclear overexpression in bladder cancer

  2017cites this paper
• Cloning and characterization of the porcine DBC1 gene encoding deleted in bladder cancer

  2015cites this paper
• Caractérisation des voies de signalisation des oncogènes FGFR3 muté et FGFR3-TACC3 dans les carcinomes de vessie

  2015cites this paper
• Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use?

  2014cites this paper
• Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder

  2014cites this paper
• Landmarks in non-muscle-invasive bladder cancer

  2014cites this paper
• Investigational cell cycle inhibitors in clinical trials for bladder cancer

  2013cites this paper
• Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens

  2013cites this paper
• Genetic instability in urinary bladder cancer: An evolving hallmark.

  2013cites this paper
• Aspekte des Harnblasenkarzinoms

  2012cites this paper
• Bladder Cancer Biology

  2012cites this paper
• The Value of the Preoperative FISH Test in Unscreened Bladder Cancer Patients with TUR Indications

  2012cites this paper
• Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

  2012cites this paper
• Molecular Pathogenesis of Bladder Cancer

  2012cites this paper
• Bladder Cancer: General Features

  2012cites this paper
• Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS)

  2012cites this paper
• Bladder: transitional cell carcinoma

  2011cites this paper
• Biomarkers in bladder cancer

  2010cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2010cites this paper
• Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.

  2010cites this paper
• 1to Carcinoma In Situ (CIS)

  2010cites this paper
• 7of Extravesical Disease: A Lack of Bladder Cancer Markers

  2010cites this paper
• Molecular pathogenesis and diagnostics of bladder cancer.

  2009cites this paper
• Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies

  2009cites this paper
• CHAPTER 31 – Bladder and Urethra

  2009cites this paper
• Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.

  2009cites this paper
• Detection of Extravesical Disease: A Lack of Bladder Cancer Markers

  2009cites this paper
• Approaches to Carcinoma In Situ (CIS)

  2009cites this paper
• Molecular biomarkers in urothelial bladder cancer

  2008cites this paper
• ESTUDIO MOLECULAR Y CITOGENÉTICO DEL CARCINOMA UROTELIAL: DETECCIÓN TEMPRANA DE LA ENFERMEDAD Y DE SU DISEMINACIÓN

  2008cites this paper
• Bladder Tumor Markers: A Review of the Literature

  2008cites this paper
• Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis

  2007cites this paper
• Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy.

  2007cites this paper
• Advances in Brief The Incidence of p 53 Mutations Increases with Progression of Head and Neck Cancer

  2007cites this paper
• Allelotype of Human Bladder Cancer 1

  2007influential citation
• p53 and retinoblastoma pathways in bladder cancer

  2007cites this paper
• Correlations Allelic Deletions in Renal Tumors : Histopathological Updated

  2007cites this paper
• Biomarkers in Bladder Cancer: Present Status and Perspectives

  2007cites this paper
• Chromosomal deletions in bladder cancer: shutting down pathways.

  2007cites this paper
• Klinische Relevanz von p53-Protein als Prognosemarker bei urothelialen Karzinomen der ableitenden Harnwege Retroprospektive Untersuchung an Patienten mit Urothelkarzinom

  2007cites this paper
• Head and Neck Cancer Mutations Increases with Progression of p 53 The Incidence of Updated Version

  2007cites this paper
• Molecular biology of bladder cancer: prognostic and clinical implications.

  2006cites this paper
• Mutations in Human Malignant Gliomas : Comparison of Loss of Heterozygosity with Mutation Frequency 1

  2006cites this paper
• Influence of Cigarette Smoking and Schistosomiasis on p53 Gene Mutation in Urothelial Cancer1

  2006cites this paper
• Loss of Heterozygosity with Mutation Frequency p 53 Mutations in Human Malignant Gliomas : Comparison of Updated

  2006cites this paper
• LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

  2006cites this paper
• DNA-based molecular cytology for bladder cancer surveillance.

  2006cites this paper
• Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging

  2006cites this paper
• Loss of 3pl3—»p21.2in Tumorigenic Reversion of a Hybrid between Isogeneic Nontumorigenic and Tumorigenic Human Uroepithelial Cells1

  2006cites this paper
• Deletion as a Genetic Marker in Urothelial Tumor by Fluorescence in Situ Hybridization '

  2006cites this paper
• MOLECULAR PROFILING OF UROTHELIAL CARCINOMA

  2006cites this paper
• Genetic and epigenetic aspects of bladder cancer

  2005cites this paper
• Cigarette Smoking and Chromosome 9 Alterations in Bladder Cancer1

  2005cites this paper
• Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets

  2005cites this paper
• Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

  2005cites this paper
• p53 anderbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer

  2005cites this paper
• Predictive Value of p 53 Mutations Analyzed in Bladder Washings for Progression of High-Risk Superficial Bladder Cancer 1

  2005cites this paper
• Bladder cancer: the molecular progression to invasive disease

  2004cites this paper
• The Clinical Significance of Molecular Markers to Bladder Cancer

  2004cites this paper
• Detection of p53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications

  2004cites this paper
• DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

  2004cites this paper
• Molecular prognostic factors in bladder cancer

  2004cites this paper
• P53 accumulation in precursor lesions and early stages of bladder cancer

  2004cites this paper
• Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer

  2004cites this paper
• Molecular pathways in bladder cancer

  2004cites this paper
• Problem of secondary malignancy after urinary diversion and cystoplasty

  2004cites this paper
• Genetic and Immunophenotype Analyses of TP53 in Bladder Cancer: TP53 Alterations Are Associated with Tumor Progression

  2004cites this paper
• Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.

  2004cites this paper
• p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions

  2004cites this paper
• Novel recurrent structural chromosomal aberrations in primary bladder cancer.

  2004cites this paper
• Current understanding of the biology of advanced bladder cancer

  2003cites this paper
• Lack of p53 Nuclear Immunostaining Is Not Indicative of Absence of TP53 Gene Mutations in Colorectal Adenocarcinomas

  2003cites this paper
• Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.

  2003cites this paper
• Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.

  2003cites this paper
• The Correlation of Tissue p53 Protein Overexpression and p53 Antigen in Serum of Patients with Bladder Cancer

  2003cites this paper
• Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma.

  2003cites this paper
• Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5

  2003cites this paper
• Molecular prognostication in bladder cancer--a current perspective.

  2003cites this paper
• Vysis® UroVysion for the detection of urothelial carcinoma

  2003cites this paper
• Molecular biology of transitional cell carcinoma.

  2003cites this paper
• Urinary Markers for Detecting Bladder Cancer

  2003cites this paper
• DNA methylation and cancer

  2002cites this paper
• Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.

  2002cites this paper
• DNA hypermethylation at the D17S5 locus is not a frequent event in human urothelial cancer

  2002cites this paper
• Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.

  2002cites this paper
• Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence.

  2002cites this paper
• Chromosomal Aberrations in Transitional Cell Carcinoma: Its Correlation with Tumor Behavior

  2002cites this paper
• Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer.

  2002cites this paper
• Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.

  2001cites this paper
• Molecular genetics of urothelial malignancies

  2001cites this paper
• Bladder Cancer

  2001cites this paper
• [Fundamental bases of urothelial carcinogenesis].

  2001cites this paper
• Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line

  2001influential citation
• The Molecular Pathogenesis of Bladder Cancer

  2001cites this paper
• FHIT gene expression in human urinary bladder transitional cell carcinomas.

  2001cites this paper